The invention discloses a marker for forecasting nasopharynx cancer transfer risk and an application thereof. The marker comprises ANXA1, CBR3, CLASP1, CXCL10, DCTN1, FNDC3B, LRIG1, FNDC3B, HDLBP, POLR2M, WSB2, WNK1, and YBX3. Molecular tags formed by 13 genetic expression formulas of the marker are capable of reflecting the biological specificity of a nasopharynx cancer patient, more accurately forecasting the transfer risk and prognosis of the nasopharynx cancer patient, and guiding clinical medication better. The forecasting efficiency to distance metastasis free survival is superior to thetraditional N-stage.